Dawn Hershman, MD, MS, FASCO
@drdawnhershman.bsky.social
Professor of Medicine and Epidemiology, Deputy Director Herbert Irving Comprehensive Cancer Center, SWOG Vice-Chair @ColumbiaMed @NYPhospital
Reposted by Dawn Hershman, MD, MS, FASCO
Columbia University's economic activity goes far beyond our campuses.
Explore our contributions to science, technology, the arts, our city, our nation, and the world, since 1754: https://www.columbia.edu/content/tradition-innovation-and-growth
Explore our contributions to science, technology, the arts, our city, our nation, and the world, since 1754: https://www.columbia.edu/content/tradition-innovation-and-growth
August 23, 2025 at 8:49 PM
Columbia University's economic activity goes far beyond our campuses.
Explore our contributions to science, technology, the arts, our city, our nation, and the world, since 1754: https://www.columbia.edu/content/tradition-innovation-and-growth
Explore our contributions to science, technology, the arts, our city, our nation, and the world, since 1754: https://www.columbia.edu/content/tradition-innovation-and-growth
What is your why? This is mine 🥹
June 11, 2025 at 11:34 AM
What is your why? This is mine 🥹
🥰
I shared the ASCO stage with Dr Dawn Hershman when we were both awarded a career development award as we were starting our careers. Amazing to share the stage with her again as we are awarded once more at #ASCO25. Truly honored and excited to do so.
June 3, 2025 at 10:37 AM
🥰
Grateful for the opportunity to partner with this cast of characters (missed you Fumiko!) to support an ASCO Young Investigator Award for Health Services Research for next year… and for the excellent party hosted by @conquercancer.bsky.social
June 1, 2025 at 1:15 PM
Reposted by Dawn Hershman, MD, MS, FASCO
Our @swog.org group chair's blog:
SWOG at ASCO, 2025
Starting with @drdawnhershman.bsky.social's Karnofsky Science of Oncology Award Lecture in the opening session, the #ASCO25 Annual Meeting will feature some great work by SWOG researchers.
www.swog.org/news-events/...
SWOG at ASCO, 2025
Starting with @drdawnhershman.bsky.social's Karnofsky Science of Oncology Award Lecture in the opening session, the #ASCO25 Annual Meeting will feature some great work by SWOG researchers.
www.swog.org/news-events/...
May 23, 2025 at 6:27 PM
Our @swog.org group chair's blog:
SWOG at ASCO, 2025
Starting with @drdawnhershman.bsky.social's Karnofsky Science of Oncology Award Lecture in the opening session, the #ASCO25 Annual Meeting will feature some great work by SWOG researchers.
www.swog.org/news-events/...
SWOG at ASCO, 2025
Starting with @drdawnhershman.bsky.social's Karnofsky Science of Oncology Award Lecture in the opening session, the #ASCO25 Annual Meeting will feature some great work by SWOG researchers.
www.swog.org/news-events/...
Reposted by Dawn Hershman, MD, MS, FASCO
Who From Oncology is Featured in TIME100 Health 2025?
@drkarenknudsen.bsky.social
@drdawnhershman.bsky.social
oncodaily.com/societies/ti...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TIME100 #Health #TIME100Health
@drkarenknudsen.bsky.social
@drdawnhershman.bsky.social
oncodaily.com/societies/ti...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TIME100 #Health #TIME100Health
Who From Oncology is Featured in TIME100 Health 2025? - OncoDaily
Discover the key oncology professionals featured in TIME100 Health 2025. and honors the most influential figures shaping cancer treatment.
oncodaily.com
May 10, 2025 at 8:26 PM
Who From Oncology is Featured in TIME100 Health 2025?
@drkarenknudsen.bsky.social
@drdawnhershman.bsky.social
oncodaily.com/societies/ti...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TIME100 #Health #TIME100Health
@drkarenknudsen.bsky.social
@drdawnhershman.bsky.social
oncodaily.com/societies/ti...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TIME100 #Health #TIME100Health
Reposted by Dawn Hershman, MD, MS, FASCO
At #ASCO25, @drdawnhershman.bsky.social will be honored with the 2025 David A. Karnofsky Memorial Award for her work in advancing cancer outcomes for all patients. #ASCODailyNews has more on her career & accomplishments: brnw.ch/21wSvbq
May 8, 2025 at 2:12 PM
At #ASCO25, @drdawnhershman.bsky.social will be honored with the 2025 David A. Karnofsky Memorial Award for her work in advancing cancer outcomes for all patients. #ASCODailyNews has more on her career & accomplishments: brnw.ch/21wSvbq
Thank you @nytimes.com for highlighting the impact of federal funding cuts on research & patient care. We share a common mission to improve the lives and wellbeing of others, and we share common values that everyone deserves the best care and treatment opportunities.
www.nytimes.com/2025/03/18/n...
www.nytimes.com/2025/03/18/n...
Trump Cuts Imperil Cancer, Diabetes and Pediatric Research at Columbia
Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.
www.nytimes.com
March 18, 2025 at 12:29 PM
Thank you @nytimes.com for highlighting the impact of federal funding cuts on research & patient care. We share a common mission to improve the lives and wellbeing of others, and we share common values that everyone deserves the best care and treatment opportunities.
www.nytimes.com/2025/03/18/n...
www.nytimes.com/2025/03/18/n...
I am profoundly grateful for this extraordinary honor 💗
Congratulations to @drdawnhershman.bsky.social, who was recently awarded the David Karnofsky Science of Oncology Award, part of @ascocancer.bsky.social 's 2025 Special Awards which recognizes "tremendous contributions to the oncology community."
Read more: connection.asco.org/do/asco-cong...
Read more: connection.asco.org/do/asco-cong...
January 27, 2025 at 10:32 PM
I am profoundly grateful for this extraordinary honor 💗
Incredible accomplishment from our @swog.org 🫁 team. 👏👏👏
1/4 @swog.org lung cancer trial, PRAGMATICA, closes early! This randomized trial enrolled 800 volunteers w stage 3-4 lung cancer in 21 months (goal was 700 in 24m). Tested chemo vs ramicirumab/pembrolizumab. Not applicable to every trial, but...
December 15, 2024 at 11:08 PM
Incredible accomplishment from our @swog.org 🫁 team. 👏👏👏
So proud of @minasedrakmd for being recognized as a @SusanGKomen rising star 💫-
December 12, 2024 at 3:33 PM
So proud of @minasedrakmd for being recognized as a @SusanGKomen rising star 💫-
New Trial Alert! The PROSPECT-Lung trial is a new @NCI study looking to improve treatment for patients with #lungcancer. Researchers aim to explore new ways to enhance survival rates & quality of life. Learn more, visit bit.ly/PROSPECTLung #NCI #NCTN #LCsm AllianceNCTN.org @swog.org
December 12, 2024 at 12:08 AM
Reposted by Dawn Hershman, MD, MS, FASCO
Excited to see #PROCTCAE and #GP5 in the inavolisib label! Recurring points in the FDA discussion about needing dose optimization in early drug development to lower doses, maintain efficacy, and improve tolerability. Also comments about needing enrollment of diverse patients. #SABCS24
December 10, 2024 at 7:21 PM
Super important not to under-treat elderly women - as life expectancy may be quite high!
#SABCS24 #bcsm #OncSky #SurgSky
Dr. R Hills: Meta-analysis of 4 older RCTs of immediate vs deferred surgery in women w/ operable ER+ #breastcancer receiving adjuvant tamoxifen. Immed surgery ⬇️ local progression, distant mets, & BC mortality. NNT <7 to prevent 1 BC death.
cc @oncoalert.bsky.social
Dr. R Hills: Meta-analysis of 4 older RCTs of immediate vs deferred surgery in women w/ operable ER+ #breastcancer receiving adjuvant tamoxifen. Immed surgery ⬇️ local progression, distant mets, & BC mortality. NNT <7 to prevent 1 BC death.
cc @oncoalert.bsky.social
December 11, 2024 at 12:29 AM
Super important not to under-treat elderly women - as life expectancy may be quite high!
Thank you all for your advocacy- I would just add - it is not just about measuring pro’s - it’s critically important to mitigate side effects early to help improve tolerance
So happy to support my friend @itsnotpink.bsky.social as she brings the @The_Right_Dose patient expert perspective on dose optimization to #SABCS24
December 10, 2024 at 9:34 PM
Thank you all for your advocacy- I would just add - it is not just about measuring pro’s - it’s critically important to mitigate side effects early to help improve tolerance
Such an important topic - so glad #SABCS24 included this in the program. More work needed to figure out how to include #PRO-cTCAE as an endpoint
Julia Maues @itsnotpink.bsky.social highlights all the ways #TheRightDoseInitiative benefits patients, physicians (shown), and payors—who pay for less sick visits and hospital stays from toxicity. #SABCS24
December 10, 2024 at 9:07 PM
Such an important topic - so glad #SABCS24 included this in the program. More work needed to figure out how to include #PRO-cTCAE as an endpoint
Reposted by Dawn Hershman, MD, MS, FASCO
S2013 and S1501 Reopen for Enrollment with Key Protocol Updates
oncodaily.com/insight/200983
@drdawnhershman.bsky.social
#Cancer #CancerTreatment #Chemotherapy #SWOG #S2013 #ICIBasedTherapy #ImmuneRelatedAdverseEvents #S1501 #OncoDaily #SWOGNCORPResearchBaseTrials #Oncology
oncodaily.com/insight/200983
@drdawnhershman.bsky.social
#Cancer #CancerTreatment #Chemotherapy #SWOG #S2013 #ICIBasedTherapy #ImmuneRelatedAdverseEvents #S1501 #OncoDaily #SWOGNCORPResearchBaseTrials #Oncology
S2013 and S1501 Reopen for Enrollment with Key Protocol Updates - OncoDaily
S2013 and S1501 Reopen for Enrollment with Key Protocol Updates / cancer, cancer treatment, chemotherapy, Dawn Hershman, ICI based therapy, immune related
oncodaily.com
December 9, 2024 at 8:41 PM
S2013 and S1501 Reopen for Enrollment with Key Protocol Updates
oncodaily.com/insight/200983
@drdawnhershman.bsky.social
#Cancer #CancerTreatment #Chemotherapy #SWOG #S2013 #ICIBasedTherapy #ImmuneRelatedAdverseEvents #S1501 #OncoDaily #SWOGNCORPResearchBaseTrials #Oncology
oncodaily.com/insight/200983
@drdawnhershman.bsky.social
#Cancer #CancerTreatment #Chemotherapy #SWOG #S2013 #ICIBasedTherapy #ImmuneRelatedAdverseEvents #S1501 #OncoDaily #SWOGNCORPResearchBaseTrials #Oncology
DART hits the target again - Razelle Kurzrock
oncodaily.com/blog/razelle...
#Cancer #OncoDaily #Oncology #Medicine #Health
oncodaily.com/blog/razelle...
#Cancer #OncoDaily #Oncology #Medicine #Health
Razelle Kurzrock: DART hits the target again - OncoDaily
Razelle Kurzrock: DART hits the target again / Adam Walter, Andrew Poklepovic, cancer, Charles D Blanke, Christine M. McLeod, Christopher W Ryan, Elad Sharon,
oncodaily.com
December 8, 2024 at 11:49 AM
Reposted by Dawn Hershman, MD, MS, FASCO
Congrats to Dr. Parminder Singh and Dr. Sonam Puri - recipients of our latest career awards supporting outstanding @swog.org research #SWOGonc
cc @moffittnews.bsky.social
thehopefoundation.org/blog/general...
cc @moffittnews.bsky.social
thehopefoundation.org/blog/general...
Singh and Puri Awarded Newest Career Engagement Award, Coltman Fellowship - The Hope Foundation
Newly Announced: More Hope Career Awards to sustain Innovative Research Dr. Sonam Puri from the Moffitt Cancer Center has been awarded a prestigious
thehopefoundation.org
December 6, 2024 at 9:14 PM
Congrats to Dr. Parminder Singh and Dr. Sonam Puri - recipients of our latest career awards supporting outstanding @swog.org research #SWOGonc
cc @moffittnews.bsky.social
thehopefoundation.org/blog/general...
cc @moffittnews.bsky.social
thehopefoundation.org/blog/general...
Reposted by Dawn Hershman, MD, MS, FASCO
Our SWOG Group Chair blog:
Modeling Adverse Event Risk Prediction: S2013 and S1501 Are Reopen to Enrollment!
Two key trials by the SWOG #NCORP Research Base have reopened after temporary closures. Both trials are prime examples of public-powered research!
www.swog.org/news-events/...
Modeling Adverse Event Risk Prediction: S2013 and S1501 Are Reopen to Enrollment!
Two key trials by the SWOG #NCORP Research Base have reopened after temporary closures. Both trials are prime examples of public-powered research!
www.swog.org/news-events/...
December 6, 2024 at 8:15 PM
Our SWOG Group Chair blog:
Modeling Adverse Event Risk Prediction: S2013 and S1501 Are Reopen to Enrollment!
Two key trials by the SWOG #NCORP Research Base have reopened after temporary closures. Both trials are prime examples of public-powered research!
www.swog.org/news-events/...
Modeling Adverse Event Risk Prediction: S2013 and S1501 Are Reopen to Enrollment!
Two key trials by the SWOG #NCORP Research Base have reopened after temporary closures. Both trials are prime examples of public-powered research!
www.swog.org/news-events/...
Reposted by Dawn Hershman, MD, MS, FASCO
#myeloMATCH is the NCI’s #precisionmedicine trial in #myeloid cancer: advanced biomarker testing in newly diagnosed acute myeloid #leukemia (#AML) or #myelodysplastic syndrome (#MDS) & treatment substudies by the Alliance, Canadian Cancer Trials Group, @eaonc.bsky.social & SWOG. swog.org/myeloMATCH
December 6, 2024 at 7:58 PM
#myeloMATCH is the NCI’s #precisionmedicine trial in #myeloid cancer: advanced biomarker testing in newly diagnosed acute myeloid #leukemia (#AML) or #myelodysplastic syndrome (#MDS) & treatment substudies by the Alliance, Canadian Cancer Trials Group, @eaonc.bsky.social & SWOG. swog.org/myeloMATCH
Reposted by Dawn Hershman, MD, MS, FASCO
"Because health insurance has become the face of both the rising premiums and the intrusive cost-containment efforts that are largely delegated to them, they have become the primary target of that anger. But it’s not just insurers," Elliott S. Fisher writes: www.statnews.com/2024/12/05/u...
Insurance companies like United Healthcare are not the only ones to blame for a broken system
The public response to United Healthcare CEO Brian Thompson’s murder misunderstands something important.
www.statnews.com
December 6, 2024 at 12:30 PM
"Because health insurance has become the face of both the rising premiums and the intrusive cost-containment efforts that are largely delegated to them, they have become the primary target of that anger. But it’s not just insurers," Elliott S. Fisher writes: www.statnews.com/2024/12/05/u...